ZVRA vs. MRVL
ZVRA (Zevra Therapeutics Inc.) and MRVL (Marvell Technology, Inc.) are both stocks. ZVRA operates in Biotechnology (Healthcare), while MRVL operates in Semiconductors (Technology). Over the past 10 years, ZVRA returned -14.94%/yr vs 38.11%/yr for MRVL. At a 0.20 correlation, their price movements are largely independent.
Performance
ZVRA vs. MRVL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ZVRA achieves a 49.00% return, which is significantly lower than MRVL's 177.90% return. Over the past 10 years, ZVRA has underperformed MRVL with an annualized return of -14.94%, while MRVL has yielded a comparatively higher 38.11% annualized return.
ZVRA
- 1D
- -4.23%
- 1M
- 2.93%
- 6M
- 57.24%
- YTD
- 49.00%
- 1Y
- 6.54%
- 3Y*
- 40.34%
- 5Y*
- 0.06%
- 10Y*
- -14.94%
MRVL
- 1D
- -3.04%
- 1M
- -15.97%
- 6M
- 183.57%
- YTD
- 177.90%
- 1Y
- 225.01%
- 3Y*
- 56.45%
- 5Y*
- 33.34%
- 10Y*
- 38.11%
ZVRA vs. MRVL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ZVRA Zevra Therapeutics Inc. | 49.00% | 7.43% | 27.33% | 42.70% | -47.30% | -22.23% | 84.70% | -78.71% | -56.05% | 37.29% |
MRVL Marvell Technology, Inc. | 177.90% | -22.82% | 83.79% | 63.68% | -57.48% | 84.62% | 80.25% | 65.74% | -23.62% | 56.89% |
Correlation
The correlation between ZVRA and MRVL is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Apr 16, 2015 | 0.20 |
The correlation between ZVRA and MRVL shifts across timeframes, from 0.17 (1 year) to 0.27 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
ZVRA:
$789.19M
MRVL:
$206.29B
ZVRA:
$2.15
MRVL:
$2.90
ZVRA:
6.21
MRVL:
81.42
ZVRA:
6.31
MRVL:
23.60
ZVRA:
3.91
MRVL:
11.56
ZVRA:
$122.29M
MRVL:
$8.72B
ZVRA:
$104.94M
MRVL:
$4.41B
ZVRA:
$149.15M
MRVL:
$4.27B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ZVRA vs. MRVL — Risk / Return Rank
ZVRA
MRVL
ZVRA vs. MRVL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Zevra Therapeutics Inc. (ZVRA) and Marvell Technology, Inc. (MRVL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ZVRA | MRVL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.82 | ||
| Sortino ratioReturn per unit of downside risk | -2.50 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.44 | -0.35 |
| Calmar ratioReturn relative to maximum drawdown | 0.26 | 8.26 | -8.01 |
| Martin ratioReturn relative to average drawdown | 0.45 | 18.47 | -18.02 |
Loading charts...
Drawdowns
ZVRA vs. MRVL - Drawdown Comparison
The maximum ZVRA drawdown since its inception was -99.27%, which is greater than MRVL's maximum drawdown of -91.60%. Use the drawdown chart below to compare losses from any high point for ZVRA and MRVL.
Loading charts...
Drawdown Indicators
| ZVRA | MRVL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.27% | -91.60% | -7.67% |
Max Drawdown (1Y)Largest decline over 1 year | -43.47% | -27.09% | -16.38% |
Max Drawdown (3Y)Largest decline over 3 years | -43.47% | -60.79% | +17.32% |
Max Drawdown (5Y)Largest decline over 5 years | -66.94% | -61.88% | -5.06% |
Max Drawdown (10Y)Largest decline over 10 years | -97.85% | -61.88% | -35.97% |
Current DrawdownCurrent decline from peak | -96.47% | -25.46% | -71.01% |
Average DrawdownAverage peak-to-trough decline | -86.47% | -46.65% | -39.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.89% | 12.10% | +12.79% |
Volatility
ZVRA vs. MRVL - Volatility Comparison
The current volatility for Zevra Therapeutics Inc. (ZVRA) is 12.44%, while Marvell Technology, Inc. (MRVL) has a volatility of 30.44%. This indicates that ZVRA experiences smaller price fluctuations and is considered to be less risky than MRVL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ZVRA | MRVL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.44% | 30.44% | -18.00% |
Volatility (6M)Calculated over the trailing 6-month period | 40.65% | 60.87% | -20.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 61.17% | 74.57% | -13.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 60.33% | 62.94% | -2.61% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 80.82% | 52.52% | +28.30% |
Dividends
ZVRA vs. MRVL - Dividend Comparison
ZVRA has not paid dividends to shareholders, while MRVL's dividend yield for the trailing twelve months is around 0.13%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRVL Marvell Technology, Inc. | 0.10% | 0.28% | 0.22% | 0.40% | 0.65% | 0.21% | 0.50% | 0.90% | 1.48% | 1.12% | 1.73% | 2.72% |
ZVRA Zevra Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ZVRA vs. MRVL - Financials Comparison
This section allows you to compare key financial metrics between Zevra Therapeutics Inc. and Marvell Technology, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ZVRA and MRVL have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MRVL has higher volatility (30.44%) compared to ZVRA (12.44%). In terms of maximum drawdown, ZVRA dropped -99.27% vs MRVL's -91.60%.
MRVL currently has the higher Sharpe Ratio (3.00 vs 0.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ZVRA and MRVL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer